Baupost Group
13F Holdings and Portfolio Analysis
Seth Klarman 2015 Q1 13F holdings, quarterly changes, portfolio value trend and position weight distribution.
Baupost Group Overview
Baupost Group held 28 stocks in 2015 Q1, with total market value around $5.95B.
Baupost Group's top five holdings in 2015 Q1: CHENIERE ENERGY INC 17.96%, VIASAT INC(VSAT) 11.55%, EBAY INC. COM(EBAY) 9.03%, Micron Technology, Inc.(MU) 8.98%, PIONEER NAT RES CO 8.70%.
- Portfolio Value
- $5.95B
- Current Holdings
- 28 stocks
- New / Increased
- 2 / 9
- Reduced / Exited
- 1 / 1
Current Holdings
| 1 | CHENIERE ENERGY INCCUSIP 16411R208 | 1.07 | 17.96% | 13.81 - | $77.40 | - | $67.90 | 0.00 | 1.25 | +$0.13B+14.00% | Held |
| 2 | VIASAT INCVSAT | 0.69 | 11.55% | 11.53 - | $59.61 | - | $71.14 | 0.00 | 2.00 | -$0.13B-16.21% | Held |
| 3 | EBAY INC. COMEBAY | 0.54 | 9.03% | 9.31 - | $57.68 | - | $53.32 | 0.00 | 1.00 | +$0.04B+8.17% | Held |
| 4 | Micron Technology, Inc.MU | 0.53 | 8.98% | 19.71 - | $27.13 | $971.00 +3479.06% | $15.43 | 0.00 | 2.00 | +$18.83B+6191.47% | Held |
| 5 | PIONEER NAT RES COCUSIP 723787107 | 0.52 | 8.70% | 3.17 | $163.51 | - | $163.51 | +3.17 | 0.25 | $0.00B0.00% | New |
| 6 | ANTERO RES CORPCUSIP 03674X106 | 0.33 | 5.55% | 9.35 +19.11% | $35.32 | - | $21.03 | +1.50 | 0.75 | +$0.13B+67.96% | Increased |
| 7 | THERAVANCE INCCUSIP 88338T104 | 0.31 | 5.23% | 19.82 - | $15.72 | - | $38.32 | 0.00 | 2.00 | -$0.45B-58.98% | Held |
| 8 | PBF ENERGY INCCUSIP 69318G106 | 0.29 | 4.94% | 8.66 - | $33.92 | - | $25.94 | 0.00 | 1.75 | +$0.07B+30.76% | Held |
| 9 | KERYX BIOPHARMACEUTICALS INCCUSIP 492515101 | 0.28 | 4.79% | 22.38 +22.30% | $12.73 | - | $14.80 | +4.08 | 1.25 | -$0.05B-13.99% | Increased |
| 10 | SUNEDISON SEMICONDUCTOR LTDCUSIP Y8213L102 | 0.20 | 3.43% | 7.90 +90.52% | $25.82 | - | $21.15 | +3.75 | 1.00 | +$0.04B+22.06% | Increased |
| 11 | ATARA BIOTHERAPEUTICS INCCUSIP 046513107 | 0.19 | 3.24% | 4.76 +90.84% | $40.48 | - | $31.68 | +2.27 | 0.50 | +$0.04B+27.76% | Increased |
| 12 | FORWARD PHARMA A/SCUSIP 34986J105 | 0.15 | 2.55% | 5.37 - | $28.32 | - | $20.83 | 0.00 | 0.50 | +$0.04B+35.96% | Held |
| 13 | THERAVANCE BIOPHARMA INCCUSIP G8807B106 | 0.11 | 1.86% | 6.37 +5.04% | $17.35 | - | $31.18 | +0.31 | 1.00 | -$0.09B-44.36% | Increased |
| 14 | VERITIV CORPCUSIP 923454102 | 0.10 | 1.69% | 2.27 -1.72% | $44.13 | - | $50.06 | -0.04 | 0.75 | -$0.01B-11.85% | Reduced |
| 15 | CHIPMOS TECH BERMUDA LTDCUSIP G2110R114 | 0.08 | 1.36% | 3.28 - | $24.66 | - | $19.13 | 0.00 | 2.00 | +$0.02B+28.89% | Held |
| 16 | CITIGROUP INCCUSIP 172967226 | 0.07 | 1.26% | 102.67 - | $0.73 | - | $0.75 | 0.00 | 2.00 | -$0.00B-2.48% | Held |
| 17 | OCWEN FINANCIAL CORP COMMON STOCKCUSIP 675746309 | 0.06 | 1.09% | 7.83 +31.29% | $8.25 | - | $21.91 | +1.87 | 0.75 | -$0.11B-62.34% | Increased |
| 18 | NOVAGOLD RES INCCUSIP 66987E206 | 0.06 | 1.08% | 21.69 - | $2.96 | - | $2.11 | 0.00 | 2.00 | +$0.02B+40.28% | Held |
| 19 | KLX INCCUSIP 482539103 | 0.06 | 0.97% | 1.50 | $38.54 | - | $38.54 | +1.50 | 0.25 | $0.00B0.00% | New |
| 20 | KOSMOS ENERGY LTDCUSIP G5315B107 | 0.06 | 0.96% | 7.24 - | $7.91 | - | $10.25 | 0.00 | 1.00 | -$0.02B-22.85% | Held |
| 21 | PARATEK PHARMACEUTICALS INCCUSIP 699374302 | 0.05 | 0.91% | 1.74 - | $31.26 | - | $35.79 | 0.00 | 0.50 | -$0.01B-12.65% | Held |
| 22 | BELLATRIX EXPLORATION LTD COMMON STOCKCUSIP 078314101 | 0.05 | 0.89% | 21.84 +20.64% | $2.43 | - | $3.43 | +3.74 | 0.50 | -$0.02B-29.22% | Increased |
| 23 | THERAVANCE INC CV SUB NTCUSIP 88338TAB0可转换债券 | 0.04 | 0.69% | 48.23 +20.31% | $0.85 | - | $0.86 | +8.14 | 0.75 | -$0.00B-0.37% | Increased |
| 24 | AMERICAN INTL GROUP INCCUSIP 026874156 | 0.03 | 0.46% | 1.25 +41.08% | $21.88 | - | $13.47 | +0.37 | 2.00 | +$0.01B+62.42% | Increased |
| 25 | KINDRED BIOSCIENCES INCCUSIP 494577109 | 0.02 | 0.36% | 3.01 - | $7.14 | - | $11.01 | 0.00 | 1.50 | -$0.01B-35.15% | Held |
Showing 1-25 of 28
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis is an estimate and can differ materially from the actual cost, especially in edge cases.
Cost basis estimate: from the latest uninterrupted holding period, new or increased shares are added to the cost pool at the report price; reductions remove shares at the then-average cost. Example: buy 100 shares at $10 in Q1 and add 50 shares at $16 in Q2, estimated cost basis is (100 x 10 + 50 x 16) / 150 = $12 per share.
Return shows estimated dollar return on top and percentage return below. It uses current price when available, otherwise report price.
Exited Holdings
Stocks no longer disclosed in the current 13F portfolio for 2015 Q1.
| 1 | SYNERON MEDICAL LTDCUSIP M87245102 | 2.42 | 1.75 | $8.70 | $9.33 | +$0.00B+7.24% |
Showing 1-1 of 1
Exited holdings are stocks disclosed in the previous report period but no longer disclosed in the current 13F portfolio.
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis uses the same weighted cost-pool method as current holdings. Estimated exit price uses the current report period weighted report price when available, otherwise the previous report price; it does not represent the actual sale price.
Exit return shows estimated dollar return on top and percentage return below.
Portfolio Visuals
Track portfolio value, position weights and Top 10 history.